Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.

Share:
More In Business
Top Dining Out Trends This Summer
OpenTable CEO joins Cheddar to discuss this summer's top restaurant trends, how best to make a reservation and what perks you can now get on the app. Watch!
Load More